CellGenix® GMP DC is optimized for the differentiation of CD14+ monocytes into mature DCs. It is used for the generation of dendritic cell therapies, which represent a new and promising immunotherapeutic approach for treatment of different types of cancer.
We offer the cytokines and growth-factors needed for optimal growth separately. This gives you the freedom to customize and create your own optimal cytokine mixture. To fit different cell and gene therapy manufacturing processes, we conveniently offer our media in both bags and in bottles.